🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great times at #ACSCC24 in SF, finally got inducted as FACS alongside with my brother Mohammed Shahait. Enjoyed meeting with the graduating class from WSU WSU-DMC Surgery Residents

🚨 Device Failures in Minimally Invasive Surgery 🚨 This study explores failures of the #AirSeal insufflation system using the FDA MAUDE database (2014–2023). Key findings: 64.7% of failures due to device breakage 🛠️ 24.1% had no identified cause, raising safety concerns ⚠️ 9

In this edition of #SIUJ, read the editorial on #urology practice in low- to middle-income countries. 📖Read this article: mdpi.com/3003038 📚Full Issue: mdpi.com/2563-6499/5/5 #OpenAccess #Journal SIU-Urology Peter Black Philippe spiess Lysanne Campeau, MD Thomas RW Herrmann

In this original research, this study reveals disparities among #urology training programs in LMICs, emphasizing the challenges faced by LMICs in providing comprehensive education. #OpenAccess #Journal 🔗 to Full Article: mdpi.com/3000506 📰 Full Issue:

Our latest study, "Post-Graduate Urology Training in Low- and Middle-Income Countries", has been published in SIUJ. 🌍 This research explores the challenges and opportunities surrounding urology training programs in Low- and Middle-Income Countries (LMICs). We highlight the

🚨 Device Failures in Minimally Invasive Surgery 🚨 This study explores failures of the #AirSeal insufflation system using the FDA MAUDE database (2014–2023). Key findings: 64.7% of failures due to device breakage 🛠️ 24.1% had no identified cause, raising safety concerns ⚠️ 9

📢 New in Société Internationale d'Urologie Journal : Dr. Albala & colleagues explore the "Current Feasibility of Urologic Telesurgery in Low/Middle Income Countries." From groundbreaking tech to barriers and global equity, they examine how telesurgery could reshape care access. 🌍 #Urology #Telesurgery

Don't miss Dr. Arthur Burnett's latest article in Société Internationale d'Urologie Journal on #HumanitarianUrology in LMICs. A compelling review of global outreach efforts, challenges, and the profound impact on both local communities and visiting aid workers. #GlobalHealth Mohamad Allaf The Johns Hopkins Brady Urological Institute

The bladder session of the First Middle East GU Oncology conference started with: A crossfire Jordanian 🇯🇴 debate about best management of MIBC : TMT Mohammad Abufaraj vs Cystectomy Mohammed Shahait American University of Beirut Medical Center American University of Beirut Faculty of Medicine

From a chat with a legend, Dr Gamal Ghoniem, to an impactful poster attracting🌎attention SUFU ! ⭐️GLP-1RA+BOTOX in 623 OAB pts →⬇️urinary retention⬇️UTIs⬇️ antispasmodics use than❌GLP-1RA ⏳Honored to be competing for best fellow poster at my 1st #SUFU2025 UCI Urology

Dear Colleague, Join the Prostate Cancer Care Disparity Analysis Project (ProGAP) (NCT06612034) by taking our quick 6–8 minute survey on global disparities in prostate cancer treatment. Your input is vital in shaping better care. Thank you! Link👇👇👇 qualtricsxmvcbtqb5rf.qualtrics.com/jfe/form/SV_7a…

🎯 please don’t forget to participate in this important survey of global disparities in prostate cancer! Alicia Morgans, MD, MPH Elena Castro Enrique Grande Rana McKay, MD, FASCO Neeraj Agarwal, MD, FASCO Asociación Argentina de Oncología Clínica (AAOC) UroTarget European Association of Urology (EAU)

📢 Reminder! Have you taken the ProGAP survey yet? Help us uncover global disparities in prostate cancer care. Just 6–8 mins of your time can shape better, fairer treatment worldwide. 🌍 Your voice matters. 👇 Link below 👇 qualtricsxmvcbtqb5rf.qualtrics.com/jfe/form/SV_7a… OncoAlert Deborah Mukherji

📰👀Finger test ‘has no role in diagnosing prostate cancer today’ We, alongside Prostate Cancer UK, have united in calling for an end to the routine use of the digital rectal examination, with it no longer being a useful test for #ProstateCancer Via The Times and The Sunday Times: thetimes.com/uk/healthcare/…

OF: Cabozantinib plus atezolizumab in metastatic prostate cancer (CONTACT-02): final analyses from a phase 3, open-label, randomised trial 📰Authors Neeraj Agarwal, MD, FASCO, Sumanta K. Pal, MD, FASCO, and colleagues thelancet.com/journals/lanon… ✏️Commentary from Deborah Mukherji, aurelius omlin thelancet.com/journals/lanon…